1 – 19 of 19
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Widespread non-joint pain in early rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Technological readiness and implementation of genomic-driven precision medicine for complex diseases
(
- Contribution to journal › Scientific review
- 2011
-
Mark
Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register
(
- Contribution to journal › Article
- 2010
-
Mark
Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006
(
- Contribution to journal › Article
- 2009
-
Mark
Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles
(
- Contribution to journal › Article
-
Mark
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas:relative risks and time-trends in the Swedish Biologics Register
(
- Contribution to journal › Article
- 2008
-
Mark
Autoantibodies in rheumatoid arthritis: Anti-citrullinated protein antibodies (ACPA) and type II collagen specificities (B cells and autoantibodies: diagnosis and pathophysiology)
2008) 28th European Workshop for Rheumatology Research In Annals of the Rheumatic Diseases 67(Suppl. 1). p.7-8(
- Contribution to journal › Published meeting abstract
- 2007
-
Mark
A case-control study of rheumatoid arthritis identifies an associated single nucleotide polymorphism in the NCF4 gene, supporting a role for the NADPH-oxidase complex in autoimmunity
(
- Contribution to journal › Article
- 2006
-
Mark
Swedish registers to examine drug safety and clinical issues in RA
(
- Contribution to journal › Scientific review
- 2005
-
Mark
CNI-1493, an inhibitor of proinflammatory cytokines, retards cartilage destruction in rats with collagen induced arthritis
(
- Contribution to journal › Article
-
Mark
Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept
(
- Contribution to journal › Article
-
Mark
Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists
(
- Contribution to journal › Article
-
Mark
Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden
(
- Contribution to journal › Article
-
Mark
Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists
(
- Contribution to journal › Article
-
Mark
MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction
(
- Contribution to journal › Article
- 2004
-
Mark
Corticosteroid treatment of experimental arthritis retards cartilage destruction as determined by histology and serum COMP
(
- Contribution to journal › Article
- 2002
-
Mark
Serum concentrations of cartilage oligomeric matrix protein, fibrinogen and hyaluronan distinguish inflammation and cartilage destruction in experimental arthritis in rats.
(
- Contribution to journal › Article
- 1999
-
Mark
A comparison of genome-scans performed in multicase families with systemic lupus erythematosus from different population groups
(
- Contribution to journal › Article
- 1981
-
Mark
Expression of major histocompatibility antigens on pancreatic islet cells
1981) In Proceedings of the National Academy of Sciences of the United States of America 78(10 I). p.6456-6460(
- Contribution to journal › Article